Purchases and Sales Made in Q1 2022 in Lava Therapeutics Nv (LVTX)
This table provides information about the institutional ownership of Lava Therapeutics Nv (LVTX) during Q1 2022. The information is specifically focused on institutions that hold shares of LAVA Therapeutics NV.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q1 2022
|
Axa S.A.
Paris, I0 |
BUY
|
- |
3.22K+ 1.41% |
$13.8K - $21.1K
|
232K
$241K
|
|
|
May 13, 2022
Q1 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
1.04K+ 10.29% |
$4.44K - $6.8K
|
11.1K
$11.6K
|
|
|
May 13, 2022
Q1 2022
|
Axa S.A.
Paris, I0 |
BUY
|
- |
2+ 0.0% |
$8.56 - $13.1
|
232K
$241K
|
|
|
May 09, 2022
Q1 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-1Closed |
$4.28 - $6.55
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-300- 74.81% |
$1.28K - $1.97K
|
101
$105
|
|
|
May 16, 2022
Q1 2022
|
Ubs Group Ag
|
SELL
|
- |
-523- 29.9% |
$2.24K - $3.43K
|
1.23K
$1.28K
|
|
|
May 13, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.53K- 35.26% |
$6.53K - $9.99K
|
2.8K
$2.91K
|
|
|
May 16, 2022
Q1 2022
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-2.17K- 1.82% |
$9.29K - $14.2K
|
117K
$122K
|
|
|
Oct 27, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2.9K- 50.88% |
$12.4K - $19K
|
2.8K
$2.91K
|
|
|
May 13, 2022
Q1 2022
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-26.6K- 7.38% |
$114K - $175K
|
334K
$348K
|
|
|
May 16, 2022
Q1 2022
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-138KClosed |
$590K - $903K
|
0
$0
|